Authors:
PACKHAM AE
SVERLOW KW
CONRAD PA
LOOMIS EF
ROWE JD
ANDERSON ML
MARSH AE
CRAY C
BARR BC
Citation: Ae. Packham et al., A MODIFIED AGGLUTINATION-TEST FOR NEOSPORA-CANINUM - DEVELOPMENT, OPTIMIZATION, AND COMPARISON TO THE INDIRECT FLUORESCENT-ANTIBODY TEST AND ENZYME-LINKED-IMMUNOSORBENT-ASSAY, Clinical and diagnostic laboratory immunology, 5(4), 1998, pp. 467-473
Authors:
KELLY ME
FITZGERALD SD
AULERICH RJ
BALANDER RJ
POWELL DC
STICKLE RL
STEVENS W
CRAY C
TEMPELMAN RJ
BURSIAN SJ
Citation: Me. Kelly et al., ACUTE EFFECTS OF LEAD, STEEL, TUNGSTEN-IRON, AND TUNGSTEN-POLYMER SHOT ADMINISTERED TO GAME-FARM MALLARDS, Journal of wildlife diseases, 34(4), 1998, pp. 673-687
Citation: Rd. Dix et al., ANTIBODY ALONE DOES NOT PREVENT EXPERIMENTAL CYTOMEGALOVIRUS RETINITIS IN MICE WITH RETROVIRUS-INDUCED IMMUNODEFICIENCY (MAIDS), Ophthalmic research, 29(6), 1997, pp. 381-392
Citation: M. Jones et al., ESTABLISHMENT OF A MURINE MODEL TO STUDY REACTIVATION OF MCMV IN MULTIPLE GVHD TARGET TISSUES FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 90(10), 1997, pp. 914-914
Citation: C. Cray, DOCTORS AND MEDICAL POLITICS - BMA IS MEETING CHANGE WITH OUTRAGED REACTION RATHER THAN ADAPTATION, BMJ. British medical journal, 312(7034), 1996, pp. 851-851
Citation: Gd. Bossart et al., CUTANEOUS PAPILLOMAVIRAL-LIKE PAPILLOMATOSIS IN A KILLER WHALE (ORCINUS-ORCA), Marine mammal science, 12(2), 1996, pp. 274-281
Citation: M. Jones et al., CONCURRENT MCMV INFECTION AUGMENTS DONOR ANTIHOST-SPECIFIC ACTIVITY AND ALTERS CLINICAL OUTCOME FOLLOWING EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION, Transplantation, 61(6), 1996, pp. 856-861
Authors:
PEREZSTABLE C
ALTMAN NH
BROWN J
HARBISON M
CRAY C
ROOS BA
Citation: C. Perezstable et al., PROSTATE, ADRENOCORTICAL, AND BROWN ADIPOSE TUMORS IN FETAL GLOBIN T-ANTIGEN TRANSGENIC MICE, Laboratory investigation, 74(2), 1996, pp. 363-373
Citation: M. Jones et al., ESTABLISHMENT OF A MURINE MODEL TO STUDY MCMV INDUCED COMPLICATIONS FOLLOWING BONE-MARROW TRANSPLANTATION ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS, The FASEB journal, 9(3), 1995, pp. 501-501
Citation: Rd. Dix et al., EVALUATION OF PEG-MODIFIED HUMAN RECOMBINANT INTERLEUKIN-2 AS IMMUNOTHERAPY FOR CYTOMEGALOVIRUS RETINITIS IN MICE WITH MAIDS, Investigative ophthalmology & visual science, 36(4), 1995, pp. 324-324
Citation: C. Cray et al., LONG-TERM IN-VIVO IMMUNE DYSFUNCTION OCCURS AFTER INFECTION WITH MOUSE HEPATITIS-VIRUS, The FASEB journal, 8(5), 1994, pp. 10000801-10000801
Citation: Sw. Cousins et al., SUSCEPTIBILITY OF MICE WITH MAIDS TO CYTOMEGALOVIRUS RETINITIS AT TIMES RELATIVE TO TH1 TH2 SHIFT/, The FASEB journal, 8(4), 1994, pp. 10000251-10000251
Citation: M. Jones et al., MCMV INDUCED COMPLICATIONS FOLLOWING EXPERIMENTAL ALLOGENEIC BONE-MARROW TRANSPLANTATION, The FASEB journal, 8(4), 1994, pp. 10000486-10000486
Citation: Rd. Dix et al., MICE IMMUNOSUPPRESSED BY MURINE RETROVIRUS INFECTION (MAIDS) ARE SUSCEPTIBLE TO CYTOMEGALOVIRUS RETINITIS, Current eye research, 13(8), 1994, pp. 587-595
Citation: Rd. Dix et al., CYTOMEGALOVIRUS RETINITIS CANNOT BE INDUCED AT TIME OF RETROVIRUS-INDUCED IMMUNE DYSREGULATION, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1647-1647
Citation: C. Cray et al., EFFECT OF PASSIVELY-ADMINISTERED HYPERIMMUNE SERUM ON CYTOMEGALOVIRUSRETINITIS IN MICE WITH MAIDS, Investigative ophthalmology & visual science, 35(4), 1994, pp. 1648-1648
Citation: C. Cray et al., INVITRO AND LONG-TERM INVIVO IMMUNE DYSFUNCTION AFTER INFECTION OF BALB C MICE WITH MOUSE HEPATITIS-VIRUS STRAIN A59/, Laboratory animal science, 43(2), 1993, pp. 169-174
Authors:
CRAY C
MATEO M
GHANEI A
HAMILTON K
ALTMAN N
ADKINS R
Citation: C. Cray et al., MOUSE HEPATITIS-VIRUS INFECTION RESULTS IN DIFFERENT ALTERATIONS INVITRO AND INVIVO IMMUNE FUNCTION IN BALB C VS C57BL/6 MICE/, The Journal of immunology, 150(8), 1993, pp. 70-70